Arrowroot Family Office’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
+1,350
| New | +$1.05M | 0.47% | 50 |
|
|
2024
Q4 | $1.03M | Buy |
1,330
+1
| +0.1% | +$772 | 0.53% | 50 |
|
|
2024
Q3 | $1.18M | Buy |
1,329
+1
| +0.1% | +$886 | 0.69% | 41 |
|
|
2024
Q2 | $1.2M | Sell |
1,328
-5
| -0.4% | -$4.53K | 0.77% | 33 |
|
|
2024
Q1 | $1.04M | Buy |
1,333
+1
| +0.1% | +$778 | 0.66% | 41 |
|
|
2023
Q4 | $776K | Buy |
1,332
+1
| +0.1% | +$583 | 0.55% | 49 |
|
|
2023
Q3 | $715K | Buy |
1,331
+10
| +0.8% | +$5.37K | 0.56% | 49 |
|
|
2023
Q2 | $619K | Buy |
1,321
+2
| +0.2% | +$938 | 0.47% | 60 |
|
|
2023
Q1 | $453K | Buy |
+1,319
| New | +$453K | 0.39% | 67 |
|